TBAJ-876 retains bedaquiline’s activity against subunits c and ε of mycobacterium tuberculosis F-ATP synthase
The antituberculosis drug bedaquiline (BDQ) inhibits Mycobacterium tuberculosis F-ATP synthase by interfering with two subunits. Drug binding to the c subunit stalls the rotation of the c ring, while binding to the ε subunit blocks coupling of c ring rotation to ATP synthesis at the catalytic α3:β3...
Saved in:
Main Authors: | Sarathy, Jickky Palmae, Ragunathan, Priya, Shin, Joon, Cooper, Christopher B., Upton, Anna M., Grüber, Gerhard, Dick, Thomas |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/138452 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
by: Kundu, Subhashri, et al.
Published: (2017) -
TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug’s uncoupler activity
by: Sarathy, Jickky Palmae, et al.
Published: (2020) -
Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase
by: Krah, Alexander, et al.
Published: (2022) -
Single mutations in the ε subunit from thermophilic Bacillus PS3 generate a high binding affinity site for ATP
by: Krah A., et al.
Published: (2019) -
Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline
by: Sarathy, J.P., et al.
Published: (2021)